The NOD-like receptors (NLRs) are cytosolic pattern-recognition receptors, which are critically involved in mucosal immune defense. The association of the NLR, NOD2, with inflammatory bowel disease first pointed to the NLRs potential function as guardians of the intestinal barrier. Since then, several studies have emphasized the importance of NLRs in maintaining gut homeostasis and intestinal infections, and in shaping the microbiota. In this review, we will highlight the function of NLRs in intestinal inflammation.
The skin and mucosal surfaces of our bodies are colonized by a vast array of micro-organisms. Although the majority of these microbes are beneficial symbionts, there are also potentially dangerous pathogens, which need to be eliminated immediately. Since there is a tight and symbiotic connection between the commensal microbiota and the host, it is important that the immune system recognizes them as harmless and prevents an inappropriate reaction (92) . Therefore, at the epithelial barrier, a well balanced immune defense has evolved to prevent the invasion of pathogens and to maintain positive host-microbiota interactions.
Key players of this epithelial immune defense repertoire are the pattern-recognition receptors (PRRs), Toll-like receptors (TLRs), and NOD-like receptors (NLRs). TLRs and NLRs recognize different molecular patterns derived by microbes or selfmolecules, which lead to the activation of different immune mechanisms such as the secretion of tumor necrosis factor (TNF)-␣ or interleukin (IL)-1␤ release.
NLRs are a highly conserved group of cytosolic receptors involved in recognition of danger-associated molecular patterns (DAMPs) and pathogen-associated molecular patterns (PAMPs). The common structure of NLRs is characterized by a central nucleotide binding and oligomerization domain (NOD) and a COOH-terminal leucine-rich repeat (LRR). NLRs can be distinguished into two subfamilies based on their NH 2 -terminal domain (FIGURE 1): 1) the NLRC subfamily consists of proteins with caspase activating and recruiting domains (CARDs), including NOD1, NOD2, and NLRC4, as well as proteins with a related but uncharacterized domain, known as X, including NLRX1, NLRC3, and NLRC5; and 2) the NLRP subfamily consists of proteins with a pyrin domain, and 14 different NLRPs are currently known (19) . Recognition of DAMPs or PAMPs by NLRs results in activation of either the NF-B and MAP kinase signaling cascade or the formation of inflammasomes (28, 57) .
In this review, we will emphasize the role of NLRs in bacterial infections and will discuss recent findings that influence the understanding of intestinal immunity. We will put an emphasis on those NLRs that have been demonstrated to play a role in intestinal homeostasis and defense, specifically, NLRP3, 6, 12, and NLRC4 as the inflammasomeactivating NLRs as well as NOD1 and NOD2.
NLRs and the Inflammasome: Intracellular Sensors of DAMPs and PAMPs
Inflammasomes are multimolecular protein complexes that assemble in the cytosol upon immune activation (FIGURE 2). Several NLRs are known to form inflammasomes together with pro-caspase-1 and the adaptor protein, apoptosis-associated speck-like protein containing a CARD (ASC) triggering caspase-1 activation and IL-1␤/IL-18 maturation (70, 104) in response to various triggers ( Table 1) .
The activation of inflammasomes is a two-step process involving 1) priming and 2) activation (reviewed in Ref. 42 ). Priming of target cells proceeds through PRR-or cytokine-induced activation, leading to the expression of inflammasome components and the production of the pro-forms of IL-1␤ and IL-18 (9, 49, 69) . Next, inflammasome formation is induced, resulting in the cleavage and activation of caspase 1. In addition to an inflammasomes-specific activating signal, K ϩ efflux is necessary for assembly (38, 79, 89) , and Ca 2ϩ and the activation of oxygen species (ROS) support inflammasomes activation (9, 23, 96, 108) . Ultimately, priming and activation of inflammasomes lead to caspase-1-induced processing and secretion of IL-1␤ and IL-18, and in some cases to the activation of a unique cell death program called pyroptosis.
NLRP3
NLRP3 has been shown to be expressed in dendritic cells, granulocytes, lymphocytes, osteoblasts, and several epithelial cell lines (60, 71) . The NLRP3 inflammasome is unique in the group of NLRs, since it can recognize ligands of diverse forms, which vary from host-derived compounds (e.g., uric acid) to pathogen-derived factors (e.g., toxins) to other xenotobiotic compounds (e.g., asbestos; reviewed in Ref. 105) . Overall, the ability of NLRP3 to sense such diverse stimuli points to a more common mediator, which has been hypothesized to be K ϩ efflux, ROS, and/or lysosomal damage, which are de facto the stimulators of NLRP3. Genome-wide association studies have recently identified single nucleotide polymorphisms within NLRP3, which are associated with Crohn's disease (21, 93, 97, 111) . Indeed, in vivo studies have highlighted the importance of NLRP3 at the mucosal barrier. However, there are controversial data supporting either a protective or a supportive function of NLRP3 in intestinal inflammation. Some studies show that mice deficient in NLRP3 are more susceptible to dextran sulphate sodium (DSS) colitis, 2,4,6-trinitrobenzenesulfonic acid (TNBS), and azoxymethane (AOM)/DSS-induced colorectal cancer, which correlates, for example, with reduced IL-1␤, IL-18, and TGF-␤ levels (1, 40, 115) . Moreover, NLRP3-deficient mice were less resistant to Citrobacter rodentium infection compared with wild-type animals, where intestinal epithelial expression of NLRP3 appeared to be key for protection (102) . In contrast, Bauer et al. detected a milder DSS-induced colitis in NLRP3-deficient mice, which was also associated with reduced cytokine release (8) . This controversy could be due to differences of experimental approaches, as Bauer et al. highlighted a time-dependent role of NLRP3 that is more important in the early phase of inflammation. This hypothesis could also explain the positive therapeutic effect of NLRP3 inhibition on DSS-induced colitis (22, 68) . The exact mechanism, however, needs to be clarified by further studies.
NLRP6
The role of NLRP6 in intestinal diseases has been a recent focus in NLR research. NLRP6 is highly expressed in intestinal epithelial cells, cells of the lamina propria, and intestinal myofibroblasts (16, 25, 84) . Hence, NLRP6 is thought to play a pivotal role in intestinal wound healing (84) .
The activating ligand of NLRP6 still remains unknown. Nevertheless, there is evidence that the stimulus, either directly or indirectly, might be of bacterial nature. Indeed, NLRP6-deficient mice are resistant to systemic E. coli, Listeria monocytogenes, and Salmonella typhimurium (S. Tm) infections (3). In addition, NLRP6 seems to be important in shaping the composition of the gut microbiota, and, consequently, Prevotellaceae is more prevalent in the microbiota of NLRP6-deficient mice (25) . Interestingly, when the perturbed microbial community is transferred to wild-type mice by co-housing, susceptibility of NLRP6-deficient mice to DSS colitis and AOM/DSS-induced colorectal cancer are likewise transmitted to wild-type animals (25, 44) . These data are supported by a recent observation that NLRP6 is involved in the regulation of mucus secretion by goblet cells; therefore, impaired NLRP6 signaling could weaken the mucus barrier and thereby impact intestinal disease (114) .
Although the role of NLRP6 in intestinal immunity needs to be further investigated, the current hypothesis is that NLRP6 plays a bifunctional role in immune defense. NLRP6 is protective against DSS colitis and AOM/DSS-induced colorectal cancer (25, 44) , but NLRP6 is also able to inhibit bacterialinduced production of NF-B-and MAPK-dependent chemokines and cytokines (3).
NLRP12
Another inflammasome member is NLRP12, which is mainly expressed in immune cells (113) . Although the activating ligand of NLRP12 still remains unknown, there is evidence that NLRP12 recognizes, either directly or indirectly, bacterial components. NLRP12 was shown to recognize Yersinia pestis and to mediate host resistance, since NLRP12-deficient mice are more susceptible to infection (112) . However, recent work of Zaki et al. identified a contrary role of NLRP12 in S. Tm infections. Here, NLRP12-deficient mice were hyperresistant to S. Tm, and NLRP12 was identified as a suppressor of S. Tm-induced proinflammatory reactions (116) . In line with this observation, NLRP12 was also reported as a suppressor of gastrointestinal inflammation upon DSS treatment and of tumorgenesis in an AOM/DSS cancer model by negative regulation of NF-B and AKT signaling (2, 117) . Interestingly, this impact of NLRP12 on tumorgenesis is primarily driven by non-hematopoietic epithelial cells, whereas early inflammation is also driven by hematopoietic cells. The divergent function of NLRP12 in different models of intestinal inflammation highlights its differential role in defense mechanisms, which seems to be pathogen specific. This, however, remains to be clarified.
NLRC4
An important function of the intestinal barrier is to distinguish commensals from pathogens. Recently, Franchi et al. identified NLRC4 as a key player in this delicate balance maintained by the immune system. Bacterial stimulation of intestinal mononuclear phagocytes (iMP) revealed that the commensals Bacterioides fragilis, Enterococcus fecalis, and Lactobacillus plantarum do not induce NLRC4-dependent release of IL-1␤, whereas Salmonella and Pseudomonas are potent stimulators of this cytokine (27) . Indeed, NLRC4 seems to be a specialized guardian of the intestinal mucosal barrier, since its expression is highly elevated in resting iMPs and epithelial crypts (27, 83) . Therefore, it is not surprising that NLRC4 was found to be protective against intestinal pathogens such as C. rodentium or S. Tm, as well as against experimental colitis models such as DSS and AOM/DSS-induced tumorigenesis (12, 14, 26, 43, 83) . Most recently, NLRC4 was found to restrict S. Tm infections through its activation of pyroptosis and expulsion of infected intestinal epithelial cells in to the lumen (98) . These latter findings highlight the importance of inflammasome activation and pyroptosis within epithelial cells for host defense.
The ligands of NLRC4 have been investigated, and flagellated bacteria such as Salmonella activate NLRC4 via flagellin (26, 75, 78) . Furthermore, PrgJ and CprI, which are components of bacterial type III secretion apparatus, also activate NLRC4 inflammasomes (55, 76, 119) . The mode of detection is via the interaction of NLRC4 with NAIP proteins, which are thought to act as adaptors that give ligand specificity to the NLRC4 inflammasome. Therefore, by interacting with NAIPs such as Naip2 or Naip5, NLRC4 inflammasomes can recognize several proteins of the type III as well as the type IV secretion apparatus (55, 119) .
Noncanonical Inflammasomes and Intracellular LPS Sensing
Recent findings have uncovered caspase 11 (caspase 4/5 in humans) as a new intracellular sensor of LPS. LPS was shown to bind directly to caspase 11, leading to its oligomerization and activation (101) . Although caspase 11 can trigger pyroptosis, co-activation of caspase 1 is required for IL-1␤/IL-18 secretion following infection of macrophages with Gram-negative bacteria (61) . Interestingly, the noncanonical inflammasome is also key for protecting epithelial cells against bacterial infection. Indeed, a recent paper showed that pyroptosis induction by caspase 11 limited bacterial colonization of the mouse intestinal epithelium by S. Tm. Moreover, in human epithelial cells, caspase 4-dependent secretion of IL-18 was induced by infection in a LPS-dependent fashion (53) . Similar to the study discussed above with NLRC4, these FIGURE 2. Activation of the inflammasome NLRP proteins are triggered to form the inflammsome, which is a protein complex that processes pro-caspase 1 to its active form. Both reactive oxygen species (ROS) and K ϩ efflux have been implicated in this activation process. Once caspase 1 is activated, it processes its substrates, including pro-IL-1, which is then released by the cell in its active form.
findings point to the activation of pyropotosis by both canonical and noncanonical inflammasomes as an intestinal barrier defense mechanism through the extrusion of infected epithelial cells.
The research on inflammasomes, especially at the intestinal epithelial barrier, is still in its infancy, hence there are many open questions to be answered. Little is known about physiological consequences of inflammasome-related mutations. Moreover, there is evidence that inflammasomes can be formed by different NLRs during the same infection. This could be an important step to adapt the immune reaction to different pathogens and should be addressed in future studies to understand the specificity of pathogen-directed immune responses. Understanding the regulatory mechanism of fine-tuning immunity, especially at the intestinal mucosal barrier, is the future goal of NLR research.
Bacterial Sensors: NOD1 and NOD2 (33, 57) . In contrast, NOD2 recognizes MDP, a PGN fragment that is found in Gram-negative and Grampositive bacteria alike (34) ( Table 1 ). The LRR region of NOD1 or NOD2 is essential for PGN detection (33, 106) , and recent evidence has revealed direct binding of these domains to PGN fragments (37, 62, 77) . It is thought that direct binding of MDP or ieDAP leads to a conformational change of the LRR horseshoe structure and to homodimerization of the NLR via the NOD domain (56, 100). Next, the adaptor protein RIP2 is recruited to the CARD domains of the homomdimer-PGN complex and forms the starting point for signal transduction leading to NFB and MAPK signaling pathways (FIGURE 3) (56) .
Signaling
NOD ligands can enter the cell through direct infection, i.e., when a cyto-invasive bacterium, like Shigella flexneri, enters the host cytosol (35) , by co-opting host peptide transporters, including hPepT1 (109) and SLC15A4 (64, 80), or through delivery by bacterial outer-membrane vesicles (OMVs; Ref. 47) . Early endosomes appear to be the platform for delivery of ligands into the cytosol.
Expression and Intracellular Localization
NOD1 is a ubiquitous NLR that is expressed in most cell types and tissues tested (28) . After the identification of NOD2 as a NLR, it was first assumed that its expression is restricted to monocytes (85) . However, further investigations revealed that NOD2 is also expressed in lymphocytes and paneth cells of the intestine (86) . A wider expression pattern of NOD2 is now generally accepted, since it was shown by several studies that NOD2 expression can be upregulated by stimulation with TNF-␣ or IFN-␥ in a number of cell types (41, 48, 95) .
Although NOD1 and NOD2 are cytosolic proteins and lack transmembrane domains, they are associated with the cytoskeleton and the plasma membrane. It was shown, for example, that NOD1 is recruited to the plasma membrane during S. flexineri infections (58) . In intestinal cell lines, NOD2 was not only found in the cytosol but also was localized at the surface and vesicle membranes, which is required for MDP-dependent activation (4, 5) . Meanwhile, several membranebound proteins were identified as interaction partners of NOD1 and NOD2, which can link them to the plasma membrane. NOD2 overexpression studies showed a colocalization to the intermediate filament protein vimentin (103) . ERBIN exclusively colocalizes with NOD2 but not with NOD1 at the plasma membrane and inhibits NOD2-dependent NF-B activation (59, 73) . Another interaction partner of NOD2 was recently identified as FERM and PDZ domain protein-containing 2 (FRMPD2), which interestingly assembles a complex with NOD2, RIP2, and ERBIN at the plasma membrane (66) . In addition, NOD1 and NOD2 were shown to recruit autophagy-related protein 16-like 1 (ATG16L1) to the plasma membrane at the site of bacterial entry, linking both receptors to autophagic activity (107) . NOD2 can also interact with the cytoskeleton through membrane-associated F-actin and can be integrated in membrane ruffles (65) . Legrand-Poels et al. concluded that the integration of NOD2 into the cytoskeleton is a regulatory mechanism to prevent its nonspecific activation and to facilitate a rapid recruitment of NOD2 upon infection. In this context, they demonstrated that the destruction of this actin-NOD2-complex leads to increased NOD2-dependent NF-B-activation. In addition, it was shown that RAC1, a Rho GTPase involved in membrane ruffling, also interacts with NOD2 and operates as an inhibitor of NOD2 (24, 65) . Interestingly, Keestra et al. discovered a similar relationship between NOD1 and RAC1 induced by the Salmonella virulence factor SopE (50) . In line with RAC1, guanine nucleotide exchange factor H1 (GEF-H1) also activates Rho GTPases, and colocalizes with NOD1 and NOD2 to serve as a modulator of RIP2-dependent NF-B activation (30, 118) . These findings are remarkable because this 1) assigns a new role to Rho GTPases within immune defense and 2) indicates that NOD1 and NOD2 not only detect PGN but also are involved in sensing cytoskeleton reorganization induced by invasive bacteria. Indeed the recent research revealed a regulatory network for NOD1 and NOD2 signaling that is more complex than initially assumed. In this context, dual oxidase 2 (DUOX2) was identified as a membrane-associated, colocalization partner of NOD2, but in contrast to RAC1, which is also a member of the NADPH oxidase complex, it supports the antibacterial function of NOD2 (67) .
Overall these studies indicate that the localization of NOD1/2 is crucial for their activation status, and further investigation is needed to understand the complex interplay of the underlying regulatory mechanisms.
Role in Intestinal Diseases
In the past decade, several genome-wide association studies identified NOD2 as the most prevalent susceptibility factor for the development of Crohn's disease (CD), emphasizing the importance of NOD2 in intestinal immunity (45, 85) . Specifically, in CD patients, mutations within NOD2 occur and are thought to be loss-of-function mutations resulting in unresponsiveness to MDP (46, 52, 81, 82) . NOD1 was also discussed as a genetic risk factor for inflammatory bowel disease (IBD); however, later genetic studies did not confirm a predisposition of NOD1 mutation to IBD (29, 74) .
NOD1 and NOD2 were also discovered to play pivotal roles in several enteric infections. In line with this, it was reported that NOD1-deficient mice are more susceptible to non-invasive Helicobacter pylori and Clostridium difficile infections (39, 110) . The importance of NOD1 in the detection of extracellular pathogens was further emphasized by Le Bourhis and colleagues, who demonstrated that NOD1 is important for the defense against a noninvasive Salmonella mutant (63) . Here, mucosal DCs are critically impaired by NOD1 deficency, since wild-type DCs normally mediate the uptake of antigens and pathogens from the luminal site of the intestine. In vitro experiments also revealed an influence of NOD1 in the defense against NOD1 and NOD2 detect peptidoglycan that can enter into the cytosol through direct bacterial infection. NOD1/2 bind RIP2, which then activates the NF-B signaling cascade, leading to the expression of pro-inflammatory genes.
invasive pathogens. Overexpression and RNAi studies showed that NOD1 is important for Listeria monocytogenes-induced chemokine secretion and NF-B activation (87) . S. flexneri also activates NOD1, and it was demonstrated that NOD1 is recruited to the bacterial entry site at the plasma membrane (35, 58) . To underline the importance of NOD1 at the mucosal barrier, chemical models, which are thought to mimic inflammatory intestinal diseases by disrupting the epithelial barrier, also were used for further investigations. Indeed NOD1-deficient mice develop exacerbated colitis upon DSS treatment and are susceptible to AOM/ DSS-induced colorectal cancer (17) .
NOD2-deficient mice are also more susceptible to colitis induced by either DSS or TNBS and show a higher risk for AOM/DSS-induced colorectal cancer (6, 20) . Several other studies have also highlighted the importance of NOD2 at the mucosal barrier to restrict bacterial infection. Helicobacter hepaticus infections lead to exacerbated intestinal inflammation in NOD2-deficient mice, which is linked to an increase of IFN-␥-secreting Th1 cells (11, 88) . In line with this, a higher bacterial burden was observed in NOD2-deficient mice upon gastrointestinal Listeria monocytogenes infections (54) . NOD2 that is bound to vimentin is able to limit the bacterial load of adherent-invasive E. coli in vitro (15, 103) . Moreover, NOD2 is important for the recruitment of monocytes through a CCL2-CCR2 axis, which is crucial for effective clearance of Citrobacter rodentium (51) .
In the past decade, S. Tm infections have become a popular tool to model colitis in mice and are frequently used to investigate NLRs in the context of intestinal immunity (7, 13) . However, in the case of NOD1 and NOD2, both receptors on their own were shown to have no influence on S. Tminduced colitis (31) . Given the high risk if one guard of the mucosal immune system is compromised by mutation or an avoidance mechanism of the pathogen, compensating mechanisms have likely evolved. Indeed, with respect to NOD1 and NOD2, it was recently shown that they can compensate for each other's deficiency in S. Tm-induced colitis as they recognize similar bacterial motifs (31) . Although mice deficient in either NOD1 or NOD2 develop colitis comparable to wild-type mice, S. Tm induces a milder colitis in NOD1-NOD2-double knockout (DKO) mice.
Using this model, a recent study by our group showed a potential interplay between NOD and TLR receptors (18) . Interestingly, infection with a S. Tm mutant with a modified lipid A moiety enhances signaling through TLR2, possibly by increasing surface exposure of TLR2 ligands as a consequence of an altered outer membrane. Using this mutant, we found that enhanced TLR2 signaling in vivo in the background of NOD deficiency led to increased inflammation in the S. Tm colitis model. These findings suggest that NOD signaling may dampen TLR2 responses in vivo, uncovering a regulatory role of NODs in TLR2-driven inflammation.
Colitis induced by C. rodentium infection also relies on NOD signaling (32) . NOD1 and NOD2 were found to be required for the induction of innate Th17 cells upon either Salmonella and Citrobacter infections. Although acute Citrobacter infection leads to milder inflammation in DKO mice, at later phases, the colitis is much more pronounced and also extended to the proximal colon in contrast to wild-type mice (32) . This raises the question of whether NOD1 and NOD2 have divergent roles during intestinal inflammation in a time-dependent manner. To answer this question in more detail, a promising S. Tm-colitis model was recently developed. Here, the usage of the attenuated strain S. Tm ⌬aroA enabled long-term intestinal Salmonella infections for the first time. The special feature of this model is the induction to Crohn's disease-like symptoms including intestinal fibrosis in C57BL/6 mice and thereby offers a tool to investigate genetic factors that are involved in fibrosis development (36, 72) . This model will help to investigate the impact of the susceptibility gene NOD2 on CD in vivo.
Because of its role in intestinal inflammation, NOD2 was considered to shape the bacterial composition in the gut. Hence, the microbiota of NOD2-deficient mice was analyzed, which in a number of studies was found to differ from wildtype mice in terms of the genus Bacteroides (10, 90) . In line with this, CD patients carrying a lossof-function variant of NOD2 also show alterations in the microbiota (91) . Despite recurrent reports of a shifted microbiota, this role of NOD2 in defining microbial community structure was recently questioned since two groups have not detected differences in the microbiota when using WT and NOD-deficient littermates (94, 99) . These surprising results were explained by the influence of housing conditions in the varying experimental approaches of the above-discussed studies. Indeed, these data highlight the need to carefully consider housing conditions as well as using F2 littermates when the effects on the microbiota are analyzed.
Conclusions
In the past decade, NLRs have been in the focus of gastrointestinal research, and their importance in mucosal immunity has been revealed. Although some NLRs such as NOD1, NOD2, or NLRC4, including their particular ligands, are already well investigated, little is known about other members of the NLR family. Hence, there is still a need to identify the motifs recognized by these NLRs. There is strong evidence that NLRs not only regulate intestinal infections but also have a critical impact on the gut homeostasis and the composition of the gut microbiota. However, it is still not fully understood how genetic alterations affecting NLRs influence the development of severe diseases such as CD. Overall, these divergent and precise functions of NLRs raise the question of how this can be regulated by the immune system. Indeed, it is assumed that there is a complex regulatory mechanism fine-tuning the mucosal immunity by NLRs. The challenge for future studies is to untangle this tightly regulated network and to identify new therapeutic targets to support these mucosal 
